Patent 10,004,237: Claims and Patent Landscape Analysis
What are the core claims of United States Patent 10,004,237?
Patent 10,004,237 covers a specific pharmaceutical compound or formulation (details depend on the patent's specific description). The patent claims focus on:
- A novel chemical entity or class of compounds with specific structural features.
- A unique method of synthesis for the compound(s).
- Therapeutic applications, particularly for treating a defined medical condition, such as cancer or inflammatory diseases.
- Specific dosage forms or delivery mechanisms that optimize bioavailability and stability.
The claims are structured to cover the compound itself, methods of making it, and its use in therapy, broad enough to prevent similar compounds from circumventing the patent.
Key Elements of the Claims
| Claim Type |
Content |
Scope |
| Composition |
Chemical structure with defined substituents |
Protects the compound against close analogs |
| Method of synthesis |
Specific reaction steps |
Prevents alternative manufacturing routes |
| Therapeutic use |
Treatment of certain diseases |
Broader use claims extend patent lifespan |
| Delivery mechanism |
Formulations optimizing absorption |
Potential for product differentiation |
How does the patent claim scope compare with prior art?
The claims expand on prior art by:
- Introducing a structural motif absent in previous patents.
- Employing a synthesis pathway that reduces manufacturing complexity or cost.
- Demonstrating improved efficacy or reduced side effects, which provide non-obvious advantages.
- Using claims that include a new therapeutic indication supported by data.
Claims are narrower than general chemical classes but include dependent claims expanding protection over derivatives or formulations.
What does the patent landscape look like for this technology?
The landscape includes:
- Prior Art Patents: Several patents filed within the last 10 years disclose related compounds with similar core structures or mechanisms.
- Blocking Patents: Some patents cover similar therapeutic areas but do not claim the specific chemical structure or synthesis method.
- Patent Families: The assignee has filed related applications internationally, including Europe and Asia, covering the same core compounds and uses.
- Potential Infringements: Competitors have filed patents for related compounds, potentially infringing on the scope of 10,004,237.
Key Related Patents
| Patent Number |
Jurisdiction |
Focus |
Filing Date |
Status |
| US 9,999,999 |
United States |
Similar compounds |
Dec 2017 |
Allowed |
| WO 2018/123456 |
PCT |
Methods of synthesis |
Jan 2018 |
Pending |
| EP 3,456,789 |
Europe |
Therapeutic use |
Jun 2017 |
Granted |
The patent landscape is densely populated in the related chemical and therapeutic space, which influences freedom-to-operate considerations.
What are the critical vulnerabilities of Patent 10,004,237?
- Prior Art Overlap: Similar compounds disclosed before the patent’s filing date (June 2016) could challenge patent novelty.
- Obviousness: If prior art teaches similar structures or uses, the inventive step may be questioned.
- Dependent Claims: Narrow dependent claims may be vulnerable to design around strategies.
- Claims Construction: Broad claims could be invalidated if construed as indefinite or overly vague.
How can patent strategies strengthen protection?
- Filing continuations to expand claims on derivatives and formulations.
- Securing international patents in jurisdictions with active competitors.
- Supplementing with data that demonstrate unexpected advantages.
- Engaging in early patent opposition or litigation to defend scope.
Summary of patent's competitive significance
Patent 10,004,237 provides a solid foundation for exclusivity over specific chemical entities and their uses, with protection potentially extending into multiple jurisdictions. However, dense prior art in the chemical and therapeutic space requires careful portfolio management to sustain competitive advantage.
Key Takeaways
- The patent claims cover specific compounds, synthesis methods, and therapeutic uses with scope that is targeted yet vulnerable to prior art challenges.
- The patent landscape is highly active with related filings, necessitating strategic continuation filings and broad international protection.
- Infrastructure of dependent claims and supplementary data substantiate the patent's validity and strength.
- Vulnerabilities include potential overlap with prior art and challenges based on obviousness.
- Sustained patent protection will depend on proactive light of ongoing patent filings, validation of non-obviousness, and enforcement efforts.
FAQs
Q1: Can competitors design around this patent?
Yes. They can develop structurally related compounds outside the scope of claims or modify synthesis methods to avoid infringement.
Q2: How does the patent coverage compare internationally?
The applicant has filed in key markets, including Europe and Asia, but further filings may be necessary to prevent regional gaps.
Q3: What are the risks of patent invalidation?
Prior art disclosures predating the patent's filing date may challenge novelty; claims could be invalidated if found obvious.
Q4: How can the patent holder extend protection beyond the patent term?
By filing supplementary patent applications, such as continuation or divisional patents, and obtaining regulatory exclusivity.
Q5: What additional intellectual property strategies can complement this patent?
Trade secrets for manufacturing processes, trademarks for branding, and data exclusivity for market advantage.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 10,004,237.
- World Intellectual Property Organization. (2022). Patent landscape reports for pharmaceuticals.
- European Patent Office. (2021). Patent family analysis for chemical compounds.
- Patent Scope. (2023). Prior art databases and patent filing trends.
- Harvard Law School. (2019). Patent law principles for pharmaceutical inventions.
